Our Team

Senior Management and Board of Directors

Advisors

Peter Frishauf Non-executive Chairman of the Board Peter, now an independent consultant, is best known as the founder of Medscape (www.medscape.com) in 1995. At the time he served as CEO of SCP Communications, Inc., the Manhattan-based medical information company he started 14 years earlier. Peter is past president of the Healthcare Marketing & Communications Council, Inc. where members from the pharmaceutical, publishing, medical education and advertising industries worked to improve educational and promotional programs. He is a director of MedPage Today, Oakstone Medical Publishing and a member of the Medical Advisory Boards of Milestone Venture Partners, TrialX, and the Markle Foundation's Connecting for Health initiative. A frequent speaker and author of hundreds of articles, Peter holds an M.S. in Journalism from Columbia University (1972); and a B.A. from NYU (1970). Peter is listed in Richard Saul Wurman's March, 2002 book, Who's Really Who as one of the 1,000 most creative people in the U.S.

Asaf Evenhaim Chief Executive Officer and Board Member Asaf is a co-founder of Crossix and serves as Chief Executive Officer. He started Crossix in 2004 with over 10 years experience in healthcare marketing and technology businesses. Asaf was the co-founder and President of SoftWatch, a leading provider of healthcare CRM Internet solutions to pharmaceutical and healthcare clients such as GlaxoSmithKline, Novartis, Aventis, Abbott Laboratories, Johnson & Johnson, Schering-Plough, Medco Health Solutions, Medscape and the American Heart Association. Asaf also served as acting CEO for Dietwatch.com, an online subscription weight loss company spun-off from SoftWatch in 1999. From 2002 to 2004, Asaf served as EVP Business Development for InterCure Inc, an innovative medical device company, where he led marketing, sales and distribution in the U.S. market to a tenfold growth in revenue run rate. Asaf served for four years in the Israeli Navy Intelligence Unit. He holds a B.Sc., cum laude, in Mathematics and Computer Science, from Tel Aviv University.

Andrew Willis EVP, CFO and Board Member Andrew is a co-founder of Crossix and serves as Executive Vice President and Chief Financial Officer. Andrew joined Crossix in 2004 from a career in Investment Banking focused on healthcare companies most recently at NM Rothschild in London where he helped to establish the Private Placement Group (PPG) in Europe for Rothschild. Andrew brings over 8 years of healthcare finance experience to Crossix. Prior to Rothschild, Andrew served as a Vice President at Credit Suisse First Boston (CSFB) in New York in its Private Finance Group where he focused on raising private capital for companies and in its Healthcare Group where he gained broad corporate finance and M&A experience working with a wide range of public and private healthcare clients. He received his B.S.B.A., magna cum laude, from Georgetown University, his M.B.A. from Columbia Business School and his J.D. from Columbia University School of Law. He is admitted to the New York State Bar.

Saar Barhoom SVP, Research & Development Saar serves as Senior Vice President, Research & Development. He joined Crossix in 2005 from Itemfield Ltd, a leader in EAI (Enterprise Application Interface) market. Saar brings over 12 years of software development experience including in healthcare IT to Crossix. Saar previously worked for Excedo Technologies, a startup in Business Activity Monitoring market, where he was in charge of building the infrastructure for Excedo's J2EE based product. Prior to that he worked with Asaf at SoftWatch for over 6 years as SoftWatch's VP R&D and Chief Architect where he was responsible for product design and development. Saar has extensive managerial and hands on experience with both Java and Microsoft's enterprise architecture infrastructure. He holds a B.A. in computer science and an M.B.A from Tel Aviv University.

Chris French Advisory Board Member Chris, an experienced chief executive officer, board chairman and practicing attorney, serves as Managing Director at Winterberry Group, a strategic consulting firm focused on direct marketing and marketing services companies. He also serves on the board of directors of Cadient Group, a leading provider of interactive brand strategy solutions to the life sciences industry. Prior to joining Winterberry Group, Mr. French was Chief Executive Officer of Cadient and spent eight years at Dendrite International, a provider of sales software, information and support service solutions to the global life sciences industry. At Dendrite, Mr. French served in several capacities, including as Senior Vice President of Global Solutions Marketing and Corporate Development. Mr. French is a graduate of Fordham University School of Law. He received a B.S. in Economics from the Wharton School of the University of Pennsylvania.

Drew Fromkin Advisory Board Member Drew currently serves as President, Chief Executive Officer, and Executive Director of Clinical Data, Inc., a global biotechnology company. He has over twenty years of senior leadership experience in key areas of the healthcare industry with an emphasis on healthcare information and services, pharmaceutical services and biotechnology. Prior to Clinical Data, Drew held senior management roles at leading and emerging healthcare companies. Most recently he was President and Chief Executive Officer of DoctorQuality, Inc., a leading provider of patient safety and condition management products that was acquired by Quantros, Inc. and served as President, Chief Executive Officer, and Director of Endo Surgical Devices, Inc., an early stage surgical device developer. Drew spent most of the 1990’s in two leadership roles with the industry’s leading prescription benefit management company (PBM), Medco, which became Merck-Medco Managed Care, LLC, a wholly owned subsidiary of Merck & Co., Inc. His leadership roles at Medco included Vice President, Business Development (Corporate Development from 1995-2000) and before that, Vice President, Sales to Major Health Insurers, Employers and Government Accounts. Drew graduated from Brandeis University, cum laude, with a B.A. in Biology and a concentration in premedical studies.

Christi van Heek Advisory Board Member Christi has 25 years of experience in the healthcare and pharmaceutical industry. Most recently she served as President, Therapeutics Division of Genzyme Corporation responsible for building world wide commercialization organizations and sales and marketing management. Under her leadership, the division expanded into over 60 countries and annual revenues grew to $700MM. In addition, she has held various other positions in sales and marketing at Genentech Corporation and Caremark, HHCA. Currently, she is founder and independent consultant focused on global commercialization, sales, marketing, and business development for BIO POINT Group. Christi holds a B.S.N. from the University of Iowa and received her M.B.A. from Lindenwood University in St. Louis.

Matt Wallach Advisory Board Member Matt currently serves as Executive Vice President and General Manager for Veeva Systems, the industry leader in Software as a Service (SaaS) CRM applications for the biopharmaceutical industry. In his previous position of Chief Marketing Officer at Health Market Science, he helped this leading provider of pharmaceutical data services double revenues and dramatically expand their customer base in two years. Prior to Health Market Science, Matt was VP of Marketing & Product Management for IntelliChem, an enterprise software company. Matt is best known for his work as the General Manager of Pharmaceuticals and Biotechnology division at Siebel Systems, the world's leading provider of customer relationship management (CRM) solutions. During his time at Siebel Systems, Matt was responsible for building this global division, which grew exponentially under his leadership, capturing greater than 80% market share in the pharmaceutical CRM and clinical trial management (CTM) markets. In 2007, Matt was recognized as one of the 100 most influential people in the life sciences industry by PharmaVOICE magazine. He holds a B.A. in Economics from Yale University and received his M.B.A. from the Harvard Business School.